About

Aims and scope

Stroke and Vascular Neurology is the official journal of the Chinese Stroke Association. Supported by a team of renowned Editors, and fully open access, the journal encourages debate on controversial techniques, issues on health policy and social medicine.

Stroke and Vascular Neurology will appeal to clinical stroke neurologists, neurosurgeons and basic neuroscientists. It will consider submissions of clinical and translational original research, short reports, editorials, and reviews to improve patient care.

Ownership

Stroke and Vascular Neurology is published by BMJ on behalf of the Chinese Stroke Association.

Chinese Stroke Association (CSA) is an academic nonprofit professional organisation dedicated to stroke prevention, therapy, rehabilitation, research, quality of care and education. CSA represents all who are involved in this area of work. CSA held its inaugural national congress in Beijing on January 18, 2015, marking the establishment of the one and only national organization in the field of cerebrovascular disease. The mission of CSA is to unite and organize the professionals and volunteers of academic, scientific and public sectors to work together to promote the scientific research and reduce stroke incidence, disability and mortality. CSA will also promote and facilitate international collaboration and establishment of the Chinese model of multidisciplinary approach for prevention and control of stroke.

Chinese Stroke Association
Building 6, Zone 3, Advanced Business Park (ABP), 188 South 4th Ring West Road, Fengtai District, Beijing, China. 100070.

Editorial board

For information about the Stroke and Vascular Neurology editorial team, please refer to the Editorial Board page.

Journal information

Publication Model Open access
Frequency Quarterly
Launch date 2016
Digital Archives Portico, LOCKSS
Indexed by Web of Science Core Collection, PubMed Central, Scopus, DOAJ, Google Scholar
Peer review model Double blind; both the reviewer and the author are anonymous to each other.
Print ISSN 2059-8688
Online ISSN 2059-8696

Journal Statistics (2020)

Acceptance rate: 25%

Speed
Days to first decision: 21 days (mean)
Days from acceptance to publication: 24 days (mean)

Impact
Impact factor (JCR): 4.765
Scimago Journal rank (SJR): 1.81
Eigenfactor: 0.00199
Citescore: 5.9

Reach
2020 total content views:216,900
2020 total Altmetric mentions: 484



The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.

How we get these metrics


Affiliations

COPE logo

The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.

Equator network logo

The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.

AllTrials logo

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.